Proffitt & Goodson’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.46K | Hold |
90
| – | – | ﹤0.01% | 215 |
|
|
2025
Q1 | $7.3K | Hold |
90
| – | – | ﹤0.01% | 211 |
|
|
2024
Q4 | $8.11K | Hold |
90
| – | – | ﹤0.01% | 205 |
|
|
2024
Q3 | $8.89K | Hold |
90
| – | – | ﹤0.01% | 218 |
|
|
2024
Q2 | $8.34K | Hold |
90
| – | – | ﹤0.01% | 230 |
|
|
2024
Q1 | $8.54K | Hold |
90
| – | – | ﹤0.01% | 197 |
|
|
2023
Q4 | $8.04K | Hold |
90
| – | – | ﹤0.01% | 190 |
|
|
2023
Q3 | $6.57K | Hold |
90
| – | – | ﹤0.01% | 198 |
|
|
2023
Q2 | $7.49K | Hold |
90
| – | – | ﹤0.01% | 192 |
|
|
2023
Q1 | $6.86K | Hold |
90
| – | – | ﹤0.01% | 200 |
|
|
2022
Q4 | $7.47K | Hold |
90
| – | – | ﹤0.01% | 201 |
|
|
2022
Q3 | $7K | Hold |
90
| – | – | ﹤0.01% | 211 |
|
|
2022
Q2 | $7K | Hold |
90
| – | – | ﹤0.01% | 221 |
|
|
2022
Q1 | $8K | Buy |
+90
| New | +$8K | ﹤0.01% | 235 |
|
|
2016
Q1 | – | Sell |
-17,015
| Closed | -$1.19M | – | 45 |
|
|
2015
Q4 | $1.19M | Sell |
17,015
-595
| -3% | -$41.8K | 0.7% | 22 |
|
|
2015
Q3 | $1.1M | Sell |
17,610
-3,855
| -18% | -$240K | 0.69% | 25 |
|
|
2015
Q2 | $1.81M | Sell |
21,465
-1,425
| -6% | -$120K | 1.05% | 10 |
|
|
2015
Q1 | $1.72M | Sell |
22,890
-2,076
| -8% | -$156K | 1% | 10 |
|
|
2014
Q4 | $1.55M | Sell |
24,966
-1,572
| -6% | -$97.7K | 0.92% | 12 |
|
|
2014
Q3 | $1.38M | Sell |
26,538
-690
| -3% | -$35.9K | 0.85% | 15 |
|
|
2014
Q2 | $1.4M | Buy |
27,228
+45
| +0.2% | +$2.31K | 0.84% | 17 |
|
|
2014
Q1 | $1.29M | Sell |
27,183
-876
| -3% | -$41.6K | 0.83% | 21 |
|
|
2013
Q4 | $1.22M | Buy |
28,059
+606
| +2% | +$26.3K | 0.79% | 23 |
|
|
2013
Q3 | $1.18M | Sell |
27,453
-1,935
| -7% | -$83.3K | 0.85% | 16 |
|
|
2013
Q2 | $1.02M | Buy |
+29,388
| New | +$1.02M | 0.79% | 26 |
|